Koryojyuhan Co., Ltd. (3495) AI Stock Analysis

• Market Cap: ¥6.69B
• Dividend Yield: 2.28%
• Average Volume (3M): 966.00
• Price to Earnings (P/E): 6.5
• Beta (1Y): 0.21
• Revenue Growth: 14.92%
• EPS Growth: 39.05%
• Country: JP
• Employees: 236
• Sector: Real Estate
• Sector Strength: 53
• Industry: Real Estate - Services
• EPS (TTM): 27.73
• Shares Outstanding: 2,764,800
• 10 Day Avg. Volume: 690
• 30 Day Avg. Volume: 966
• PEG Ratio: 0.00
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 60 Neutral
• Price Target: ¥2,532.00 ▲(4.80% Upside)

The stock's overall score is driven by a solid valuation with a low P/E ratio and decent dividend yield. However, financial performance concerns, including declining revenue and negative cash flows, weigh heavily. Technical indicators show neutral to bearish sentiment, further impacting the score.

Positive Factors

Business Model Strength

The company's focus on pharmaceuticals and medical devices provides a stable revenue base, leveraging diverse therapeutic areas and market segments.

Innovation in Healthcare

Strong R&D capabilities enhance product offerings and patient outcomes, supporting long-term growth and competitive positioning in healthcare.

Profitability Margins

Stable margins indicate efficient operations and cost management, providing a buffer against revenue fluctuations and supporting financial health.

Negative Factors

Declining Revenue

Declining revenue suggests challenges in market demand or competitive pressures, potentially impacting long-term growth and market share.

Negative Cash Flows

Negative cash flows indicate potential liquidity issues, limiting the company's ability to invest in growth and manage financial obligations.

Rising Leverage

Increasing leverage raises financial risk, potentially constraining flexibility and increasing vulnerability to economic downturns.

Koryojyuhan Co., Ltd. Business Overview & Revenue Model

Company Description

Koryojyuhan Co., Ltd. operates as a real estate company in Japan. The company offers rental agency, monthly apartment, trunk room, and elderly housing services. It is also involved in the buying and selling brokerage, real estate purchase/sale, residential lot sales, and development and sale of real estate properties. In addition, the company provides rental management, renovation proposal, vacant house management, and sublease services. Further, the company offers profitable real estate consulting, coin parking, and real estate fund business services; and solar power generation facility services. Koryojyuhan Co., Ltd. was incorporated in 1981 and is headquartered in Mito, Japan.

How the Company Makes Money

Koryojyuhan Co., Ltd. generates revenue primarily through the sale of its pharmaceutical products, which include both prescription and over-the-counter medications. The company has established a diverse portfolio of drugs that cater to various therapeutic areas, enabling it to tap into multiple market segments. Additionally, Koryojyuhan may also earn income from licensing agreements and partnerships with other healthcare organizations, which can include collaborative research initiatives and co-marketing arrangements. The company's ability to maintain regulatory compliance and secure necessary approvals for its products further enhances its revenue potential, as does its investment in marketing and distribution channels to reach healthcare providers and consumers effectively.

Koryojyuhan Co., Ltd. Financial Statement Overview

Summary

Koryojyuhan Co., Ltd. shows strong revenue growth and profitability with effective cost management and operational efficiency. The balance sheet is stable with a balanced leverage approach. However, challenges in cash flow generation require strategic focus to enhance liquidity and financial resilience.

Income Statement

Koryojyuhan Co., Ltd. has demonstrated consistent revenue growth over the years, with a notable increase of 7.6% in the most recent year. The gross profit margin remains strong at 38.9%, indicating effective cost management. Net profit margin improved to 7.2%, reflecting enhanced profitability. EBIT and EBITDA margins are solid at 10% and 14.1%, respectively, showcasing operational efficiency. However, the company should continue to monitor cost structures to sustain these margins.

Balance Sheet

The balance sheet reveals a moderate debt-to-equity ratio of 1.36, indicating a balanced approach to leverage. Return on equity is healthy at 13.7%, suggesting efficient use of equity capital. The equity ratio stands at 32.1%, reflecting a stable financial structure. While the company maintains a reasonable level of equity, it should be cautious of increasing debt levels to avoid potential financial strain.

Cash Flow

Cash flow analysis indicates challenges in generating positive free cash flow, with a negative free cash flow growth rate. The operating cash flow to net income ratio is negative, highlighting issues in converting profits into cash. Despite these challenges, the company has managed financing activities effectively to support operations. Improving cash flow generation remains crucial for financial flexibility.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	11.58B	11.53B	10.04B	9.32B	8.71B	7.80B
Gross Profit	4.15B	4.13B	3.90B	3.60B	3.45B	3.21B
EBITDA	1.44B	1.38B	1.42B	1.21B	1.08B	856.93M
Net Income	1.03B	1.02B	722.10M	653.18M	493.05M	391.25M
Balance Sheet
Total Assets	16.38B	17.84B	16.41B	14.13B	11.51B	9.56B
Cash, Cash Equivalents and Short-Term Investments	2.74B	2.25B	2.20B	1.85B	1.81B	2.03B
Total Debt	6.16B	7.41B	7.17B	5.97B	4.35B	3.24B
Total Liabilities	10.28B	11.64B	11.15B	9.49B	7.47B	5.91B
Stockholders Equity	6.10B	6.20B	5.26B	4.64B	4.05B	3.65B
Cash Flow
Free Cash Flow	0.00	-711.81M	-1.08B	-1.72B	-1.29B	412.22M
Operating Cash Flow	0.00	-646.44M	-712.22M	-1.42B	-319.94M	609.28M
Investing Cash Flow	0.00	552.82M	7.30M	-282.34M	-1.04B	-185.16M
Financing Cash Flow	0.00	109.69M	1.08B	1.72B	1.12B	-81.05M

Koryojyuhan Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2416.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3495, the sentiment is Positive. The current price of 2416 is above the 20-day moving average (MA) of 2409.85, below the 50-day MA of 2429.88, and above the 200-day MA of 2149.37, indicating a neutral trend. The MACD of -8.76 indicates Negative momentum. The RSI at 49.91 is Neutral, neither overbought nor oversold. The STOCH value of 53.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3495.

Koryojyuhan Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3241	76 Outperform	¥6.87B	7.64	―	3.22%	18.41%	54.19%
5527	69 Neutral	¥9.84B	7.20	―	3.40%	28.82%	672.17%
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
3261	65 Neutral	¥4.58B	33.99	―	1.72%	7.47%	148.01%
4437	65 Neutral	¥4.33B	15.17	―	0.67%	10.71%	-26.92%
3495	60 Neutral	¥6.69B	6.49	―	2.28%	14.92%	39.05%
3237	40 Neutral	¥3.35B	-7.27	―	―	4.15%	-14.18%